Publications
54
Citations
848
Est. group size
~1
Recurring co-author estimate
Active years
52
Publishing since 1975
- Supporting data and analysis for," A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease", main figures PART 2
Zenodo (CERN European Organization for Nuclear Research) · 2023
- Supporting data and analysis for," A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease", main figures PART 1
Zenodo (CERN European Organization for Nuclear Research) · 2023
- Supporting data and analysis for," A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease", Supplemental 3DTC figures
Zenodo (CERN European Organization for Nuclear Research) · 2023
- Supporting data and analysis for," A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease", Supplemental 3DTC figures
Zenodo (CERN European Organization for Nuclear Research) · 2023
- Supporting data and analysis for," A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease", main figures PART 1
Zenodo (CERN European Organization for Nuclear Research) · 2023
- Supporting data and analysis for," A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease", main figures PART 2
Zenodo (CERN European Organization for Nuclear Research) · 2023
- Supporting data and analysis for," A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease", Supplemental 3DTC figures
Zenodo (CERN European Organization for Nuclear Research) · 2023
- A model for improving and assessing outpatient antibiotic stewardship interventions for common upper respiratory tract infections and UTI, to improve appropriate outpatient antibiotic prescribing in order to improve patient safety, patient cost, and reduce antimicrobial resistance in accordance with the Joint Commission goal of reducing outpatient antibiotic prescriptions for 2020.
UNM’s Digital Repository (University of New Mexico) · 2020
- Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague
Vaccine · 2019
- A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4+ T and Natural Killer Cells
Cancer Research · 2019
- Abstract 4145: A novel form of 4-1BB agonist shows robust immune protection against various tumor types through CD4<sup>+</sup>memory-like T and NK cell axis
Immunology · 2019
- Abstract 4145: A novel form of 4-1BB agonist shows robust immune protection against various tumor types through CD4+ memory-like T and NK cell axis
Cancer Research · 2019
- A novel agonist of CD137 immune checkpoint stimulator serves as a cancer immunoprevention agent with efficacy against various tumor types
The Journal of Immunology · 2019
- Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance
Nature Materials · 2018
- Current challenges for cancer vaccine adjuvant development
Expert Review of Vaccines · 2018
- Zenodo (CERN European Organization for Nuclear Research)×7
- Journal of the American Society of Nephrology×6
- The Journal of Immunology×4
- Transplantation×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile